Noah L. Rosenberg insider trades

Open-market stock purchases and sales by Noah L. Rosenberg, CMO at Verrica Pharmaceuticals Inc, from SEC Form 4 filings since Jul 23, 2013.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -3%.

Recent trades

DateStockTradeValue
Aug 18, 2026VRCA Verrica Pharmaceuticals IncBought$10K
Aug 17, 2026VRCA Verrica Pharmaceuticals IncBought$20.6K
Jun 5, 2026VRCA Verrica Pharmaceuticals IncBought (not open market)—
Nov 25, 2025VRCA Verrica Pharmaceuticals IncBought$10K
Nov 25, 2025VRCA Verrica Pharmaceuticals IncBought$3.7K

Companies traded

  • VRCA Verrica Pharmaceuticals Inc: 4 buys, last Aug 18, 2026
  • TVTX Travere Therapeutics, Inc: 10 sales, last Aug 17, 2021
  • RTRX Retrophin, Inc: 7 sales, last Sep 23, 2020
  • ESPR Esperion Therapeutics, Inc: other filings, last Jul 23, 2013

Get free alerts when Noah L. Rosenberg files a new trade →